Design and synthesis of nano-biomaterials based on graphene and local delivery of cerebrolysin into the injured spinal cord of mice, promising neural restoration

Ayda Yari-Ilkhchi,Mehrdad Mahkam,Abbas Ebrahimi-Kalan,Hamid Soltani Zangbar
DOI: https://doi.org/10.1039/d3na00760j
IF: 5.598
2024-01-23
Nanoscale Advances
Abstract:Spinal cord injury (SCI) is an incurable and catastrophic health issue with no clinical solution. As part of cascade reactions, the inflammatory process and fibrous glial scar production aggravate the amount of lesion through a secondary damage mechanism, encouraging scientists from other disciplines to investigate new paths for solving this problem. Graphene oxide (GO) and its derivatives are among the most promising biomedical and nerve tissue regeneration materials due to their remarkable chemical, mechanical, and electrical properties. This paper designs and introduces a new GO-based nanomaterial to minimize inflammation and stimulate neurite regrowth. To improve biocompatibility, biodegradability, and cell proliferation, GO plates were modified with polyethylene glycol (PEG) and Au nanoparticles as neuroprotective and antibacterial agents, respectively. Preliminary biological investigations on bone marrow derived mesenchymal stem cells (BM-MSCs) with various concentrations of a graphenic nanocarrier indicated a lack of cell toxicity and an enhancement in BM-MSC proliferation of about 10% after 48 hours. Therapeutic nanostructures were used in the T10 segment of a mouse SCI model. The pathological and immunohistochemical data revealed that refilling tissue cavities, decreasing degeneration, and establishing neuroregeneration resulted in a considerable improvement of hind limb motor function. Furthermore, compared to the nanocomposite mixture alone, the intraspinal delivery of cerebrolysin (CRL) had a more satisfying impact on nerve regrowth, cystic cavity, hemorrhage avoidance, and motor function enhancement. This study demonstrates the potential of graphenic nanomaterials for SCI treatment and neuroregeneration applications.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?
### The Problem the Paper Attempts to Solve This paper aims to address the currently incurable and catastrophic health issue of Spinal Cord Injury (SCI). SCI leads to sensory, motor, and autonomic dysfunctions that severely impact the quality of life of patients and impose significant personal and societal burdens. Despite progress in understanding the degenerative mechanisms and treatment methods of SCI, nearly 3 million people worldwide are still affected, with annual medical costs exceeding $4 billion. Specifically, the paper attempts to solve the following key issues by designing and synthesizing graphene-based nanobiomaterials: 1. **Reducing Inflammatory Response**: After SCI, the inflammatory process and the formation of fibrous glial scars exacerbate the extent of the injury, leading to secondary damage. The new materials proposed in the paper aim to mitigate this inflammatory response. 2. **Promoting Nerve Regeneration**: Traditional treatment methods have limited effectiveness in promoting nerve regeneration. By designing novel graphene-based nanomaterials, the paper aims to stimulate the regeneration of nerve axons. 3. **Enhancing Biocompatibility and Degradability**: To ensure the safety and efficacy of the new materials, the paper modifies graphene oxide (GO) by adding polyethylene glycol (PEG) and gold nanoparticles (AuNPs) to enhance biocompatibility and antibacterial properties. 4. **Localized Delivery of Therapeutic Drugs**: The paper explores the effects of locally delivering Cerebrolysin (CRL) to the injured spinal cord to further improve nerve regeneration and motor function recovery. In summary, this research aims to provide new effective approaches for the treatment of SCI and nerve regeneration by developing and applying graphene-based nanobiomaterials.